Torrent Pharmaceuticals Ltd.

View in App
1774.00 -1.15 ▼-0.1%

02 June 2023, 04:01:00 PM
Volume: 25,800

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 60,134.99 Cr.
Enterprise Value(EV) 64,860.99 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 36.79 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 48.23 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 183.14 Trailing Twelve Months Ending 2023-03
Price to Book Value 9.69 Calculated using Price: 1,774.00
Dividend Yield 1.24 Period Ending 2022-03
No. of Shares Subscribed 33.84 Cr. 338,445,440 Shares
FaceValue 5
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Torrent Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Torrent Pharmaceuticals Ltd. Performance

View details >>
1 Day
-0.06%
1 Week
+4.22%
1 Month
+7.19%
3 Month
+18.30%
6 Month
+9.53%
1 Year
+26.04%
2 Year
+26.97%
5 Year
+144.06%
10 Year
+801.93%

Torrent Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.94 34.19 57.92 23.80 15.12 9.34 21.47 23.49 13.18
Return on Capital Employed (%) 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35
Return on Assets (%) 15.16 11.71 20.89 10.28 5.81 3.15 7.50 9.20 5.92

Torrent Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953 6,198
Non Curr. Liab. 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238 2,823
Curr. Liab. 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415 5,447
Minority Int. 0 0 0 0 1
Equity & Liab. 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468
Non Curr. Assets 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,312 9,139
Curr. Assets 3,404 4,051 4,680 4,879 5,262 5,038 4,979 5,522 5,165 5,329
Misc. Exp. not W/O
Total Assets 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468

Torrent Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 4,185 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,508 9,620
Other Income 38 286 229 223 307 64 121 57 197 45
Total Income 4,223 4,939 6,896 6,039 6,257 7,736 8,061 8,061 8,705 9,665
Total Expenditure -3,233 -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,524 -6,077 -6,778
PBIDT 990 1,306 2,959 1,601 1,648 2,040 2,292 2,537 2,628 2,887
Interest -59 -175 -184 -206 -308 -504 -451 -353 -255 -333
Depreciation -87 -191 -238 -307 -409 -618 -654 -658 -662 -707
Taxation -180 -189 -610 -155 -253 -125 -162 -274 -449 -611
Exceptional Items -194 -357 -485
PAT 664 751 1,733 934 678 436 1,025 1,252 777 1,236
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 664 751 1,733 934 678 436 1,025 1,252 777 1,236
Adjusted EPS 20 22 51 28 20 13 30 37 23 37

Torrent Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803
Cash Fr. Inv. -242 -356 -2,162 -838 -787 -4,707 -241 199 -449 -197
Cash Fr. Finan. 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781
Net Change -68 330 -140 469 29 -395 242 42 -95 -175
Cash & Cash Eqvt 687 955 865 1,050 1,068 702 940 662 573 398

Torrent Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Torrent Pharmaceuticals Ltd. Announcements

View details >>
Tue, 30 May 2023
Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI(Listing Obligations And Disclosure Requirements) 2015 ("Listing Regulations")
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI(Listing Obligations and Disclosure Requirements) 2015 ("Listing Regulations")
Tue, 30 May 2023
Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) 2015 ("Listing Regulations")
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) 2015 ("Listing Regulations")
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Board Recommended to the members a final dividend of ? 8/- (160%) per equity share of ? 5 each. The final dividend amount if declared by the Shareholders is proposed to be paid / dispatched on or around 14th August 2023. Earlier an interim dividend of ? 14/- (280%) per equity share was paid during the last quarter

Torrent Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 5 Years High Increase in 5 Years

Torrent Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Zydus Lifesciences Ltd. 52,487.85 519.40 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 26.82 519.40 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 3.00 519.40 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 519.40 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 519.40 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 519.40 +1.2%

Torrent Pharmaceuticals Ltd. FAQ's

What is Torrent Pharma share price?
Can I buy Torrent Pharma shares now?
What is the Dividend Yield of Torrent Pharma?
What is the Market Cap of Torrent Pharma?
What are the key metrics to analyse Torrent Pharma?
What is the 52 Week High and Low of Torrent Pharma?
What is the trend of Torrent Pharma share price?